These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 35034624)
1. SMAD4-201 transcript as a putative biomarker in colorectal cancer. Babic T; Dragicevic S; Miladinov M; Krivokapic Z; Nikolic A BMC Cancer; 2022 Jan; 22(1):72. PubMed ID: 35034624 [TBL] [Abstract][Full Text] [Related]
2. SMAD7 and SMAD4 expression in colorectal cancer progression and therapy response. Rosic J; Dragicevic S; Miladinov M; Despotovic J; Bogdanovic A; Krivokapic Z; Nikolic A Exp Mol Pathol; 2021 Dec; 123():104714. PubMed ID: 34717960 [TBL] [Abstract][Full Text] [Related]
3. Dysregulation of transcripts SMAD4-209 and SMAD4-213 and their respective promoters in colon cancer cell lines. Babic T; Ugrin M; Jeremic S; Kojic M; Dinic J; Banovic Djeri B; Zoidakis J; Nikolic A J Cancer; 2024; 15(15):5118-5131. PubMed ID: 39132157 [No Abstract] [Full Text] [Related]
4. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis. Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of loss of heterozygosity and sub-cellular localization of SMAD4 varies with tumor stage in colorectal cancer. Jia X; Shanmugam C; Paluri RK; Jhala NC; Behring MP; Katkoori VR; Sugandha SP; Bae S; Samuel T; Manne U Oncotarget; 2017 Mar; 8(12):20198-20212. PubMed ID: 28423626 [TBL] [Abstract][Full Text] [Related]
6. Loss of SMAD4 Promotes Colorectal Cancer Progression by Recruiting Tumor-Associated Neutrophils via the CXCL1/8-CXCR2 Axis. Ogawa R; Yamamoto T; Hirai H; Hanada K; Kiyasu Y; Nishikawa G; Mizuno R; Inamoto S; Itatani Y; Sakai Y; Kawada K Clin Cancer Res; 2019 May; 25(9):2887-2899. PubMed ID: 30705034 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-20a-5p promotes colorectal cancer invasion and metastasis by downregulating Smad4. Cheng D; Zhao S; Tang H; Zhang D; Sun H; Yu F; Jiang W; Yue B; Wang J; Zhang M; Yu Y; Liu X; Sun X; Zhou Z; Qin X; Zhang X; Yan D; Wen Y; Peng Z Oncotarget; 2016 Jul; 7(29):45199-45213. PubMed ID: 27286257 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathological characteristics of SMAD4 gene expressions in colorectal cancer patients. Mansouri N; Mozooni Z; Haghighi M; Soleimani S; Ghadyani R; Parsazad E; Azari S; Rezaei Tavirani M; Kahrizi S; Rouhollahpour Ahangar E; Movafagh A Cell Mol Biol (Noisy-le-grand); 2024 Oct; 70(9):176-180. PubMed ID: 39380261 [TBL] [Abstract][Full Text] [Related]
9. Antimetastatic role of Smad4 signaling in colorectal cancer. Zhang B; Halder SK; Kashikar ND; Cho YJ; Datta A; Gorden DL; Datta PK Gastroenterology; 2010 Mar; 138(3):969-80.e1-3. PubMed ID: 19909744 [TBL] [Abstract][Full Text] [Related]
10. Black Raspberries Suppress Colorectal Cancer by Enhancing Smad4 Expression in Colonic Epithelium and Natural Killer Cells. Huang YW; Lin CW; Pan P; Shan T; Echeveste CE; Mo YY; Wang HT; Aldakkak M; Tsai S; Oshima K; Yearsley M; Xiao J; Cao H; Sun C; Du M; Bai W; Yu J; Wang LS Front Immunol; 2020; 11():570683. PubMed ID: 33424832 [TBL] [Abstract][Full Text] [Related]
11. A SMAD4-modulated gene profile predicts disease-free survival in stage II and III colorectal cancer. Szeglin BC; Wu C; Marco MR; Park HS; Zhang Z; Zhang B; Garcia-Aguilar J; Beauchamp RD; Chen XS; Smith JJ Cancer Rep (Hoboken); 2022 Jan; 5(1):e1423. PubMed ID: 34114372 [TBL] [Abstract][Full Text] [Related]
12. Smad4-mediated signaling inhibits intestinal neoplasia by inhibiting expression of β-catenin. Freeman TJ; Smith JJ; Chen X; Washington MK; Roland JT; Means AL; Eschrich SA; Yeatman TJ; Deane NG; Beauchamp RD Gastroenterology; 2012 Mar; 142(3):562-571.e2. PubMed ID: 22115830 [TBL] [Abstract][Full Text] [Related]
13. Silencing Smad4 attenuates sensitivity of colorectal cancer cells to cetuximab by promoting epithelial‑mesenchymal transition. Lin Z; Zhang L; Zhou J; Zheng J Mol Med Rep; 2019 Oct; 20(4):3735-3745. PubMed ID: 31485652 [TBL] [Abstract][Full Text] [Related]
14. Downregulated USP3 mRNA functions as a competitive endogenous RNA of SMAD4 by sponging miR-224 and promotes metastasis in colorectal cancer. Wang Z; Yang J; Di J; Cui M; Xing J; Wu F; Wu W; Yang H; Zhang C; Yao Z; Zhang N; Jiang B; Su X Sci Rep; 2017 Jun; 7(1):4281. PubMed ID: 28655924 [TBL] [Abstract][Full Text] [Related]
15. TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4. Liang Q; Tang C; Tang M; Zhang Q; Gao Y; Ge Z J Exp Clin Cancer Res; 2019 Apr; 38(1):159. PubMed ID: 30979374 [TBL] [Abstract][Full Text] [Related]
16. SMAD4 alteration associates with invasive-front pathological markers and poor prognosis in colorectal cancer. Oyanagi H; Shimada Y; Nagahashi M; Ichikawa H; Tajima Y; Abe K; Nakano M; Kameyama H; Takii Y; Kawasaki T; Homma KI; Ling Y; Okuda S; Takabe K; Wakai T Histopathology; 2019 May; 74(6):873-882. PubMed ID: 30636020 [TBL] [Abstract][Full Text] [Related]
17. Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway. Zhang B; Zhang B; Chen X; Bae S; Singh K; Washington MK; Datta PK Br J Cancer; 2014 Feb; 110(4):946-57. PubMed ID: 24384683 [TBL] [Abstract][Full Text] [Related]
18. Smad4 acts as tumor suppressor by antagonizing lymphangiogenesis in colorectal cancer. Liu Y; Sheng J; Dai D; Liu T; Qi F Pathol Res Pract; 2015 Apr; 211(4):286-92. PubMed ID: 25680269 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of reduced SMAD4 expression in patients with metastatic colorectal cancer under oxaliplatin-containing chemotherapy: a translational study of the AIO colorectal study group. Baraniskin A; Munding J; Schulmann K; Meier D; Porschen R; Arkenau HT; Graeven U; Schmiegel W; Tannapfel A; Reinacher-Schick A Clin Colorectal Cancer; 2011 Mar; 10(1):24-9. PubMed ID: 21609932 [TBL] [Abstract][Full Text] [Related]
20. The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers. Kodach LL; Wiercinska E; de Miranda NF; Bleuming SA; Musler AR; Peppelenbosch MP; Dekker E; van den Brink GR; van Noesel CJ; Morreau H; Hommes DW; Ten Dijke P; Offerhaus GJ; Hardwick JC Gastroenterology; 2008 May; 134(5):1332-41. PubMed ID: 18471510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]